Highlights Eurofins Scientific SE Deutsche Boerse AG

Equities

End-of-day quote Deutsche Boerse AG Other stock markets 23:00:00 04/02/2024 GMT			5-day change	1st Jan Change
53.62 ^EUR	-1.07%		-4.59%	-9.73%

05-13	Eurofins Scientific to Expand US Battery Materials Testing Capabilities	MT
05-13	Eurofins Scientific expands capacity in the USA	CF

Eurofins Scientific to Expand US Battery Materials Testing Capabilities	05-13	MT
Eurofins Scientific expands capacity in the USA	05-13	CF
Corella Resources Confirms High Purity Alumina Production	05-08	MT
CAC40: France's rating maintained = non-event	04-29	CF
CAC40: starts the week slightly up, crosses the 8100 mark	04-29	CF
CAC40: interest rates soar, pulling back below 8100 pts	04-24	CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed	04-24
CAC40: reverses course under pressure from rates at their zenith	04-24	CF
CAC40: rise to 8.150, but interest-rate tensions hinder progress	04-24	CF
Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired.	04-23	CI
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	04-05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	04-05	CF
CAC40: ends the day balanced after a salvo of statistics	04-04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	04-04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	04-04	CF
CAC40: up slightly after PMI figures	04-04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	04-03	MT
Eurofins completes acquisition of Ascend Clinical	04-03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	04-02	CI
CAC40: ends with a balanced performance, helped by the banking sector	03-28	CF

No results for this search

EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed

April 24, 2024 at 04:50 pm